Biblio

56 Ergebnisse exportiert:

Autor Titel [ Typ

] Jahr

Filterkriterien: Filter is [Alle Filter deaktivieren]

Journal Article

Saaristo A, Veikkola T, Enholm B, Hytönen M, Arola J, Pajusola K, u. a.. Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes. FASEB J [Internet]. 2002;16(9):1041 - 9. http://view.ncbi.nlm.nih.gov/pubmed/12087065

Anne Saaristo et al., FASEB Journal 2002 (966.08 KB)

Enholm B, Karpanen T, Jeltsch M, Kubo H, Stenback F, Prevo R, u. a.. Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin. Circ Res [Internet]. 2001;88(6):623 - 9. http://view.ncbi.nlm.nih.gov/pubmed/11282897

Bernd Enholm et al., Circulation Research 2001 (2.93 MB)

Anisimov A, Alitalo A, Korpisalo P, Soronen J, Kaijalainen S, Leppänen V-M, u. a.. Activated forms of VEGF-C and VEGF-D provide improved vascular function in skeletal muscle. Circ Res [Internet]. 2009;104(11):1302 - 12. http://view.ncbi.nlm.nih.gov/pubmed/19443835

Andrey Anisimov et al., Circulation Research 2009 (8.03 MB)

Andrey Anisimov et al., Circulation Research 2009, supplement (5.9 MB)

Conference Paper

Jeltsch M. What you should know about VEGF-C when working with lymphatics [German]. In Lymphologie 2017 [Internet]. Bad Soden (Frankfurt), Germany; 2017. https://jeltsch.org/Abstrakt-BadSoden2017

Extended Abstract (published in Vasomed, 2018) (226.5 KB)

Jussila L, Veikkola T, Jeltsch M, Thurston G, McDonald D, Achen M, u. a.. Signalling via VEGFR-3 is sufficient for lymphangiogenesis in transgenic mice. In Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications. Miami Beach, Florida; 2001.

Jussila et al., 2001 (279.47 KB)

Jeltsch M. Drug-induced lymphangiogenesis. In 3. Schweizer Lymphsymposium [Internet]. Juzo; 2021. https://doi.org/10.5281/zenodo.6034307

Jeltsch - 2021 - Drug-induced lymphangiogenesis (1.9 MB)

Seiten